Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2008;51:1651-1657
Published online before print April 21, 2008, doi: 10.1161/HYPERTENSIONAHA.107.105668
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
51/6/1651    most recent
HYPERTENSIONAHA.107.105668v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schnabel, R.
Right arrow Articles by Benjamin, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schnabel, R.
Right arrow Articles by Benjamin, E. J.
Right arrowPubmed/NCBI databases
*SNP
Medline Plus Health Information
*High Blood Pressure
Related Collections
Right arrow Risk Factors
Right arrow Other diagnostic testing
Right arrow Epidemiology
Right arrow Genetics of cardiovascular disease
Right arrow Other Vascular biology

(Hypertension. 2008;51:1651.)
© 2008 American Heart Association, Inc.


Original Articles

Relations of Inflammatory Biomarkers and Common Genetic Variants With Arterial Stiffness and Wave Reflection

Renate Schnabel; Martin G. Larson; Josée Dupuis; Kathryn L. Lunetta; Izabella Lipinska; James B. Meigs; Xiaoyan Yin; Jian Rong; Joseph A. Vita; Christopher Newton-Cheh; Daniel Levy; John F. Keaney, Jr; Ramachandran S. Vasan; Gary F. Mitchell; Emelia J. Benjamin

From the National Heart Lung and Blood Institute Framingham Study (R.S., M.G.L., J.D., K.L.L., D.L., I.L., C.N.-C., R.S.V., E.J.B.), Framingham, Mass; Departments of Mathematics and Statistics (M.G.L.), Biostatistics (J.D., K.L.L.), and Epidemiology (E.J.B.), Public Health School, Whitaker Cardiovascular Institute (J.A.V., R.S.V., E.J.B.), Evans Memorial Department of Medicine (J.A.V., R.S.V., E.J.B.), and Department of Preventive Medicine (R.S.V., E.J.B.), School of Medicine, Boston University, Boston, Mass; Center for Population Studies (D.L.), National Heart, Lung, and Blood Institute, Bethesda, Md; Department of Medicine (J.B.M.), Division of Cardiology (C.N.-C.), Massachusetts General Hospital, Harvard Medical School, Boston; University of Massachusetts Medical School (J.F.K.), Broad Institute of Harvard and Massachusetts Institute of Technology (C.N.-C.), Cambridge, Mass; and Cardiovascular Engineering, Inc (G.F.M.), Waltham, Mass.

Correspondence to Emelia J. Benjamin, Boston University School of Medicine, Framingham Heart Study, 73 Mount Wayte Ave, Framingham, MA 01702-5827. E-mail emelia{at}bu.edu

Inflammation causes vascular dysfunction and perpetuates proatherosclerotic processes. We hypothesized that a broad panel of inflammatory biomarkers and single nucleotide polymorphisms in inflammatory genes is associated with vascular stiffness. We assessed 12 circulating inflammatory biomarkers (C-reactive protein, fibrinogen, interleukin-6, intercellular adhesion molecule-1, lipoprotein-associated phospholipase-A2 [mass and activity], monocyte chemoattractant protein-1, myeloperoxidase, CD40 ligand, osteoprotegerin, P-selectin, and tumor necrosis factor receptor-II) in relation to tonometry variables (central pulse pressure, mean arterial pressure, forward pressure wave, reflected pressure wave, carotid-femoral pulse wave velocity, and augmentation index) measured in 2409 Framingham Heart Study participants (mean age: 60 years; 55% women; 13% ethnic/racial minorities). Single nucleotide polymorphisms (n=2195) in 240 inflammatory candidate genes were related to tonometry measures in 1036 white individuals. In multivariable analyses, biomarkers explained <1% of any tonometry measure variance. Applying backward elimination, markers related to tonometry (P<0.01) were as follows: tumor necrosis factor receptor-II (inversely) with mean arterial pressure; C-reactive protein (positively) and lipoprotein-associated phospholipase-A2 (inversely) with reflected pressure wave; and interleukin-6 and osteoprotegerin (positively) with carotid-femoral pulse wave velocity. In genetic association analyses, lowest P values (false discovery rate <0.50) were observed for rs10509561 (FAS), P=6.6x10–5 for central pulse pressure and rs11559271 (ITGB2), P=1.1x10–4 for mean arterial pressure. These data demonstrate that, in a community-based sample, circulating inflammatory markers tumor necrosis factor receptor-II (mean arterial pressure), C-reactive protein, lipoprotein-associated phospholipase-A2 activity (reflected pressure wave), interleukin-6, and osteoprotegerin (carotid-femoral pulse wave velocity) were significantly but modestly associated with measures of arterial stiffness and wave reflection. Additional studies are needed to determine whether variation in inflammatory marker genes is associated with tonometry measures.


Key Words: tonometry • inflammation • epidemiology • polymorphism • single nucleotide • genetics




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
A. Upadhyay, S.-J. Hwang, G. F. Mitchell, R. S. Vasan, J. A. Vita, P. I. Stantchev, J. B. Meigs, M. G. Larson, D. Levy, E. J. Benjamin, et al.
Arterial Stiffness in Mild-to-Moderate CKD
J. Am. Soc. Nephrol., September 1, 2009; 20(9): 2044 - 2053.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc GenetHome page
R. B. Schnabel, K. L. Lunetta, M. G. Larson, J. Dupuis, I. Lipinska, J. Rong, M.-H. Chen, Z. Zhao, J. F. Yamamoto, J. B. Meigs, et al.
The Relation of Genetic and Environmental Factors to Systemic Inflammatory Biomarker Concentrations
Circ Cardiovasc Genet, June 1, 2009; 2(3): 229 - 237.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. Lacolley, P. Challande, M. Osborne-Pellegrin, and V. Regnault
Genetics and pathophysiology of arterial stiffness
Cardiovasc Res, March 1, 2009; 81(4): 637 - 648.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
W. Schumacher, J. Cockcroft, N. J. Timpson, C. M. McEniery, J. Gallacher, A. Rumley, G. Lowe, G. D. Smith, I. B. Wilkinson, and Y. Ben-Shlomo
Association Between C-Reactive Protein Genotype, Circulating Levels, and Aortic Pulse Wave Velocity
Hypertension, February 1, 2009; 53(2): 150 - 157.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W. Lieb, M. G. Larson, E. J. Benjamin, X. Yin, G. H. Tofler, J. Selhub, P. F. Jacques, T. J. Wang, J. A. Vita, D. Levy, et al.
Multimarker Approach to Evaluate Correlates of Vascular Stiffness: The Framingham Heart Study
Circulation, January 6, 2009; 119(1): 37 - 43.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. A. Duprez
Genetic Variants of Inflammatory Markers and Arterial Stiffness
Hypertension, June 1, 2008; 51(6): 1472 - 1473.
[Full Text] [PDF]